TABLE 2.

CHARACTERISTICS OF PATIENTS INCLUDED IN BAL ANALYSES

		Sarcoidosis
Variable	Control (n = 12)	Nonsevere (n = 18)	Severe (n = 18)
Age, years*	34 ± 9	39 ± 7	48 ± 9
Sex (male/female)	6/6	14/4	10/8
Race (white/black/other)	7/4/1	16/1/1	8/10/0
Smoking history (none/former/active)	10/2/0	13/3/2	16/1/1
BAL differential*
Lymphocytes, %	5 ± 4	16 ± 13	19 ± 13
PMNs, %	1 ± 2	1 ± 1
CXR stage
1		10	1
2		7	8
3		1	2
4		0	7
FVC, % predicted	n/a	94 ± 15	79 ± 22
DlCO, % predicted*	n/a	95 ± 17	77 ± 22

Definition of abbreviations: BAL = bronchoalveolar lavage; CXR = chest X-ray; PMN = polymorphonuclear leukocyte.

^*Mean ± SD.